Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-03-11 @ 11:15 PM
Study NCT ID:
NCT02330705
Status:
UNKNOWN
Last Update Posted:
2019-01-25
First Post:
2014-12-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Timing of HCG Administration in IUI Cycles
Sponsor:
Mohamed Ibrahem Eid
Organization:
Study Overview
Official Title:
Timing of Human Chorionic Gonadotropin Administration in Intrauterine Insemination Cycles
Status:
UNKNOWN
Status Verified Date:
2019-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.
Detailed Description:
Women will be randomly divided into 3 groups; the first group will undergo IUI at the time HCG administration, the second group will undergo IUI 12 hours after HCG administration and the third group will undergo IUI 34-36 hours after HCG administration.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: